Bladder-Cancer-banner-NEW v2
 

Please feel free to forward to your colleagues and share the news of our journal

Dear Colleague,

We are delighted to announce the publication of Volume 5, Issue 1 of Bladder Cancer (BLC). The full contents are freely available online and can be browsed in full below.

This issue hosts an outstanding selection of articles, including the systematic review of prospective clinical trials of therapeutic agents with HER2 activity. From the editors of the regular journal sections, there are also new Challenging Case, Clinical Trials Corner, and Paper Alert contributions.

BLC-purple-divider

Call for Papers

As a member of our research community, we would like to invite you to contribute your own research articles to Bladder Cancer, which offers contributing authors many benefits:

• First class Editorial Board
• Rigorous peer review and speedy manuscript processing
• Rapid online publication (pre-press) on acceptance
• Articles are currently published Open Access with no article processing fee

Submit your manuscript online via msTracker
View detailed Instructions to Authors
Aims and Scope

We look forward to working with you.

Best wishes,

Editors-in-Chief

Seth P. Lerner, MD
Scott Department of Urology
Baylor College of Medicine
Houston, Texas, USA
Email: blc@iospress.com

Dan Theodorescu, MD, PhD
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, California, USA
Email: blc@iospress.com

BLC-purple-divider

All articles are freely available to all readers

Systematic Review: Targeting HER2 in Bladder Cancer
Koshkin, Vadim S. | O’Donnell, Peter | Yu, Evan Y. | Grivas, Petros

The Outcome of Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Patients with Metastatic Bladder Cancer in the Retroperitoneum
Liu, Nick W. | Murray, Katie S. | Donat, S. Machele | Herr, Harry W. | Bochner, Bernard H. | Dalbagni, Guido

Thermo Reversible Hydrogel Based Delivery of Mitomycin C (UGN-101) for Treatment of Upper Tract Urothelial Carcinoma (UTUC)
Kleinmann, Nir | Wirth, Gregory | Lin, Jeffrey S. | Matin, Surena F. | Nativ, Ofer | Mayer, Gil | Witjes, J. Alfred | Shvero, Asaf | Chamie, Karim | Pantuck, Allan J. | Smith, Angela | Schoenberg, Mark | Malchi, Nadav | Hakim, Gil | Agmon-Gerstein, Yael | Jeshurun-Gutshtat, Michal | Klein, Ifat | Kopelen, Helen | Lerner, Seth P.

Assessment of a European Bladder Cancer Predictive Model for Non-Muscle Invasive Bladder Cancer in an Australian Cohort
Alberto, Matthew | Demkiw, Stephanie | Goad, Jeremy | Jenkins, Mark | Duggan, Genevieve | Mow, Tyler | Wong, Lih-Ming

Multi-Perspective Tolerance Evaluation of Bacillus Calmette-Guerin with Interferon in the Treatment of Non-Muscle Invasive Bladder Cancer
Steinberg, Ryan L. | Thomas, Lewis J. | Mott, Sarah L. | O’Donnell, Michael A.

Recovering from Cystectomy: Patient Perspectives
McMullen, Carmit K. | Kwan, Marilyn L. | Colwell, Janice C. | Munneke, Julie R. | Davis, James V. | Firemark, Alison | Brooks, Neon | Grant, Marcia | Gilbert, Scott M. | Altschuler, Andrea

Immune Checkpoint B7x (B7-H4/B7S1/VTCN1) is Over Expressed in Spontaneous Canine Bladder Cancer: The First Report and its Implications in a Preclinical Model
Chand, Damini | Dhawan, Deepika | Sankin, Alexander | Ren, Xiaoxin | Lin, Juan | Schoenberg, Mark | Knapp, Deborah W. | Zang, Xingxing

Intravesical Therapy – BCG and Beyond
Grossman, H. Barton | Lamm, Donald | Sjödahl, Gottfrid | O’Donnell, Michael | Hahn, Noah | Kamat, Ashish

Challenging Cases in Urothelial Cancer
Soloway, Mark S.

Clinical Trials Corner
Agarwal, Piyush K. | Sternberg, Cora N.

Paper Alert: Smoking Cessation in Bladder Cancer Patients
Messing, Edward M.

BLC-purple-divider

Most Viewed BLC Articles 2018

Via the IOS Press content website

Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer (Research Article in Vol.1, Iss.1, 2015)
Steinberg, Ryan L. | Thomas, Lewis J. | O’Donnell, Michael A. | Nepple, Kenneth G.

Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer (Review Article in Vol.4, Iss.1, 2018)
Sherif, Amir | Winerdal, Malin | Winqvist, Ola

Chemotherapy for Invasive Bladder Cancer: Five Simple Rules Learned Over 30 Years (Review Article in Vol.1, Iss.1, 2015)
Raghavan, Derek

Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer (Review Article in Vol.4, Iss.1, 2018)
Todenhöfer, Tilman | Struss, Werner J. | Seiler, Roland | Wyatt, Alexander William | Black, Peter C.

Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis (Research Article in Vol.4, Iss.1, 2018)
Westhoff, Ellen | Witjes, J. Alfred | Fleshner, Neil E. | Lerner, Seth P. | Shariat, Shahrokh F. | Steineck, Gunnar | Kampman, Ellen | Kiemeney, Lambertus A. | Vrieling, Alina

BLC-purple-divider

BCAN News

BCAN's Young Investigator Awards 2019 | Apply Now

Applications are currently open for two Young Investigator Awards (YIA), of $50,000 each, to support one year of research. Deadline for YIA applications to submit a research proposal is: Monday, February 25, 2019.

BCAN is designating an additional YIA for Patient-Centered Clinical Research. To compete for this award, investigators must be working in a research environment capable of supporting transformational patient-oriented clinical bladder cancer research (e.g. studies of access to care, quality of care, quality of life, health disparities, and patient-centered outcomes research). Deadline for applicants to submit a research proposal is: Monday, February 25, 2019.

For further details, visit the BCAN website.

BLC-purple-divider

Please Share the BLC Newsletter With Your Colleagues

Help Spread the News of BLC!

If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the visual or access the sign-up link here.

BLC has an active social media presence. If you are not yet interacting with the journal on social media, why not take the time today to follow us on Twitter?

Be part of the discussion!

BLC-purple-divider
 
 
Powered by Mad Mimi®A GoDaddy® company